Son Euncheol, Lee Dongju, Woo Chul-Woong, Kim Young-Hoon
Department of Pharmacology, University of Ulsan College of Medicine, Seoul 05505, Korea.
Bio-Medical Institute of Technology, University of Ulsan, Seoul 05505, Korea.
Korean J Physiol Pharmacol. 2020 Mar;24(2):173-183. doi: 10.4196/kjpp.2020.24.2.173. Epub 2020 Feb 20.
An model for ischemia/reperfusion injury has not been well-established. We hypothesized that this failure may be caused by serum deprivation, the use of glutamine-containing media, and absence of acidosis. Cell viability of H9c2 cells was significantly decreased by serum deprivation. In this condition, reperfusion damage was not observed even after simulating severe ischemia. However, when cells were cultured under 10% dialyzed FBS, cell viability was less affected compared to cells cultured under serum deprivation and reperfusion damage was observed after hypoxia for 24 h. Reperfusion damage after glucose or glutamine deprivation under hypoxia was not significantly different from that after hypoxia only. However, with both glucose and glutamine deprivation, reperfusion damage was significantly increased. After hypoxia with lactic acidosis, reperfusion damage was comparable with that after hypoxia with glucose and glutamine deprivation. Although high-passage H9c2 cells were more resistant to reperfusion damage than low-passage cells, reperfusion damage was observed especially after hypoxia and acidosis with glucose and glutamine deprivation. Cell death induced by reperfusion after hypoxia with acidosis was not prevented by apoptosis, autophagy, or necroptosis inhibitors, but significantly decreased by ferrostatin-1, a ferroptosis inhibitor, and deferoxamine, an iron chelator. These data suggested that in our SIR model, cell death due to reperfusion injury is likely to occur ferroptosis, which is related with ischemia/reperfusion-induced cell death . In conclusion, we established an optimal reperfusion injury model, in which ferroptotic cell death occurred by hypoxia and acidosis with or without glucose/glutamine deprivation under 10% dialyzed FBS.
缺血/再灌注损伤的模型尚未完全确立。我们推测,这种失败可能是由于血清剥夺、使用含谷氨酰胺的培养基以及缺乏酸中毒所致。血清剥夺显著降低了H9c2细胞的活力。在这种情况下,即使模拟严重缺血后也未观察到再灌注损伤。然而,当细胞在10%透析胎牛血清中培养时,与在血清剥夺条件下培养的细胞相比,细胞活力受影响较小,并且在缺氧24小时后观察到了再灌注损伤。缺氧条件下葡萄糖或谷氨酰胺剥夺后的再灌注损伤与仅缺氧后的再灌注损伤无显著差异。然而,同时进行葡萄糖和谷氨酰胺剥夺时,再灌注损伤显著增加。缺氧合并乳酸酸中毒后的再灌注损伤与缺氧合并葡萄糖和谷氨酰胺剥夺后的再灌注损伤相当。尽管高代H9c2细胞比低代细胞对再灌注损伤更具抗性,但尤其是在缺氧以及葡萄糖和谷氨酰胺剥夺合并酸中毒后观察到了再灌注损伤。缺氧合并酸中毒后再灌注诱导的细胞死亡不能被凋亡、自噬或坏死性凋亡抑制剂阻止,但铁死亡抑制剂铁抑素-1和铁螯合剂去铁胺可显著降低细胞死亡。这些数据表明,在我们的SIR模型中,再灌注损伤导致的细胞死亡很可能是铁死亡,这与缺血/再灌注诱导的细胞死亡有关。总之,我们建立了一个最佳的再灌注损伤模型,在该模型中,在10%透析胎牛血清条件下,无论有无葡萄糖/谷氨酰胺剥夺,缺氧和酸中毒都会导致铁死亡性细胞死亡。